27
Participants
Start Date
June 30, 2012
Primary Completion Date
October 9, 2017
Study Completion Date
October 16, 2017
Dalfampridine
Dalfampridine 10 mg tablet, twice-daily, for 10 weeks
Placebo
Placebo tablet, twice daily, for 10 weeks.
Kessler Institute for Rehabilitation, West Orange
Lead Sponsor
Collaborators (1)
National Institute on Disability, Independent Living, and Rehabilitation Research
FED
Acorda Therapeutics
INDUSTRY
Kessler Foundation
OTHER